XML 70 R53.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2023
Omnibus Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Changes in Restricted Shares

The following table discloses the changes in all unvested restricted shares for the year ended December 31, 2023:

 

 

Omnibus Plan

 

 

 

Number of Shares

 

 

Weighted Average Grant Date Fair Value

 

Beginning balance, January 1, 2023

 

 

581,337

 

 

$

22.93

 

Granted

 

 

305,117

 

 

 

24.34

 

Incremental performance shares vested and issued

 

 

1,826

 

 

 

 

Vested

 

 

(238,638

)

 

 

21.18

 

Forfeited

 

 

(22,371

)

 

 

23.48

 

Ending balance outstanding at December 31, 2023

 

 

627,271

 

 

 

24.24

 
BYB Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Activity in shares Subjected to Options and Weighted Average Exercise Prices

The following table discloses the activity in shares subject to options and the weighted average exercise prices, in actual dollars, for the year ended December 31, 2023:

 

 

BYB Plan

 

 

 

Number of Shares

 

 

Weighted Average Exercise Price

 

 

Intrinsic Value

 

 

Weighted Average Remaining Contractual Term (in Years)

 

Beginning balance, January 1, 2023

 

 

768,564

 

 

$

11.31

 

 

$

8,960

 

 

 

2.5

 

Expired

 

 

—

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

—

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

—

 

 

 

 

 

 

 

 

 

 

Ending balance outstanding at December 31, 2023

 

 

768,564

 

 

$

11.31

 

 

$

9,413

 

 

 

1.5

 

Exercisable at December 31, 2023

 

 

768,564

 

 

$

11.31

 

 

$

9,413

 

 

 

1.5

 
FEB Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Activity in shares Subjected to Options and Weighted Average Exercise Prices

The following table discloses the activity in shares subject to options under the FEB Plan and the weighted average exercise prices, in actual dollars, for the year ended December 31, 2023:

 

 

FEB Plan

 

 

 

Number of Shares

 

 

Weighted Average Exercise Price

 

 

Intrinsic Value

 

 

Weighted Average Remaining Contractual Term (in Years)

 

Beginning balance, January 1, 2023

 

 

162,288

 

 

$

11.66

 

 

$

1,836

 

 

 

2.5

 

Exercised

 

 

(59,153

)

 

$

11.14

 

 

$

590

 

 

 

 

Forfeited

 

 

—

 

 

 

 

 

 

 

 

 

 

Expired

 

 

—

 

 

 

 

 

 

 

 

 

 

Ending balance outstanding at December 31, 2023

 

 

103,135

 

 

$

11.95

 

 

$

1,197

 

 

 

1.9

 

Exercisable at December 31, 2023

 

 

103,135

 

 

$

11.95

 

 

$

1,197

 

 

 

1.9

 
Restricted Shares  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Stock Compensation Expense

The following table summarizes restricted stock compensation expense for the years ended:

 

 

Years Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Total share-based compensation - restricted stock

 

$

6,715

 

 

$

5,334

 

 

$

4,018

 

Income tax benefit

 

 

1,806

 

 

 

1,474

 

 

 

1,108

 

Unrecognized compensation expense - restricted stock

 

 

9,371

 

 

 

9,151

 

 

 

6,991

 

Weighted-average amortization period remaining

 

1.9 years

 

 

2.3 years

 

 

2.2 years